Lawyers began selecting jurors to hear a lawsuit accusing healthcare giant Johnson & Johnson of liability for patient injuries allegedly caused by the company's transvaginal mesh implants.
MASSDEVICE ON CALL — A bellwether trial against Johnson & Johnson (NYSE:JNJ) began this month with lawyers beginning to select jurors to hear a lawsuit accusing the healthcare giant of liability patient injuries allegedly caused by the company's transvaginal mesh implants.
Plaintiff Linda Gross claims that J&J subsidiary Ethicon's Prolift implant left her with severe chronic pain that prevents her from working or even sitting.
Decisions made in this trial, which is taking place in New Jersey and expected to take about 2 months, may trickle down to similar lawsuits against C.R. Bard (NYSE:BCR), Endo Pharmaceuticals Holdings (NSDQ:ENDP) and Boston Scientific (NYSE:BSX).
Courts in West Virgina are slated in February to begin hearing cases against makers of transvaginal mesh implants, starting with a lawsuit against Bard.
J&J's Prolift device has been at the center of controversy over whether or not J&J marketed the device to doctors and patients without proper FDA approval.
21st Century Cures, a bipartisan panel led by Reps. Fred Upton (R-Mich.) and Diana DeGette (D-Colo...
The FDA approves St. Jude Medical's FlexAbility ablation catheter for treating cardiac fibrillation...
Stryker reports slumping profits for the 4th quarter and all of 2014, blaming in part the recalls of...
Abiomed wins a humanitarian device exemption for its Impella RP